Eagle Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Eagle Asset Management's BMY Position: Q3 2024 in Review
Eagle Asset Management opened a new position in Bristol-Myers Squibb (BMY) in Q3 2024: 54,691 shares worth $2.96M. The stake represents 0.02% of the portfolio and ranks #439 among its holdings. This is a return to the name: Eagle Asset Management previously reported a position in BMY as recently as Q3 2023.
Eagle Asset Management first reported a position in BMY in Q4 2019 and has held it in 17 quarters since. The position peaked at $9.51M in Q2 2022. 2,258 funds tracked by Wall St. Rank hold BMY as of Q3 2024.
- Eagle Asset Management held 54,691 shares of Bristol-Myers Squibb worth $2.96M as of Q3 2024.
- Bristol-Myers Squibb was a new Eagle Asset Management position in Q3 2024.
- Bristol-Myers Squibb made up 0.02% of Eagle Asset Management's portfolio in Q3 2024, its #439 holding.
- Eagle Asset Management first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 17 quarters since.
- Eagle Asset Management's Bristol-Myers Squibb position peaked at $9.51M in Q2 2022.
- 2,258 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.
Based on Eagle Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.